The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Open accessAbstract
BACKGROUND: The extent to which diabetes mellitus or hyperglycemia is related to risk of death from cancer or other nonvascular conditions is uncertain. METHODS: We calculated hazard ratios for cause-specific death, according to baseline diabetes status or fasting glucose level, from individual-participant data on 123,205 deaths among 820,900 people in 97 prospective studies. RESULTS: After adjustment for age, sex, smoking status, and body-mass index, hazard ratios among persons with diabetes as compared with persons without diabetes were as follows: 1.80 (95% confidence interval [CI], 1.71 to 1.90) for death from any cause, 1.25 (95% CI, 1.19 to 1.31) for death from cancer, 2.32 (95% CI, 2.11 to 2.56) for death from vascular causes, and 1.73 (95% CI, 1.62 to 1.85) for death from other causes. Diabetes (vs. no diabetes) was moderately associated with death from cancers of the liver, pancreas, ovary, colorectum, lung, bladder, and breast. Aside from cancer and vascular disease, diabetes (vs. no diabetes) was also associated with death from renal disease, liver disease, pneumonia and other infectious diseases, mental disorders, nonhepatic digestive diseases, external causes, intentional self-harm, nervous-system disorders, and chronic obstructive pulmonary disease. Hazard ratios were appreciably reduced after further adjustment for glycemia measures, but not after adjustment for systolic blood pressure, lipid levels, inflammation or renal markers. Fasting glucose levels exceeding 100 mg per deciliter (5.6 mmol per liter), but not levels of 70 to 100 mg per deciliter (3.9 to 5.6 mmol per liter), were associated with death. A 50-year-old with diabetes died, on average, 6 years earlier than a counterpart without diabetes, with about 40% of the difference in survival attributable to excess nonvascular deaths. CONCLUSIONS: In addition to vascular disease, diabetes is associated with substantial premature death from several cancers, infectious diseases, external causes, intentional self-harm, and degenerative disorders, independent of several major risk factors. (Funded by the British Heart Foundation and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prediabetes is linked with increased risks of major manifestations of vascular disease, but it remains unclear whether the elevated disease risks depend on development of clinical diabetes.84,85”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [85]
In the citing paper
“A recent individual-level evidence from prospective studies suggests that fasting hyperglycaemia (figure 3), postload glucose, and A1c are all robust predictors of vascular mortality86,88,89 and, according to multivariable adjusted analyses, these associations are independent of vascular risk factors, such as obesity, blood pressure, triglyceride and lipoproteins.84,85,87”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [85]
In the citing paper
“The study found that a 50-year-old with T2DM died, on average, 6 years earlier than an individual without T2DM, with about 40% of the difference in survival attributable to excess non-vascular deaths.95”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [95]
In the citing paper
“Aside from CV death, results from the Emerging Risk Factors Collaboration, including 820 900 people, demonstrate that T2DM is independently associated with increased risk of death from several cancers (i.e.liver, pancreas, ovary, colorectum, lung, bladder, and breast), renal and liver disease, pneumonia and other infectious diseases, mental and nervous system disorders, non-hepatic digestive dis”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [95]
In the citing paper
“These are consistent with downward secular trends in cardiovascular disease and improvements in mortality and are in line with previously reported estimates of the reduction in life expectancy due to diabetes [23].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Self-citationMortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 1,010
Diabetes and Cause-Specific Mortality in Mexico City
Alegre-Díaz, J., Herrington, W. G., López‐Cervantes, M., Gnatiuc, L., Ramirez, R., Hill, M., Baigent, C., McCarthy, M. I., Lewington, S., Collins, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1605368 · Cited by 282
NETosis is induced by high glucose and associated with type 2 diabetes
Menegazzo, L., Ciciliot, S., Poncina, N., Mazzucato, M., Persano, M., Bonora, B. M., Albiero, M., de Kreutzenberg, S. V., Avogaro, A., & Fadini, G. P. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0676-x · Cited by 281
Physical activity in obesity and metabolic syndrome
Strasser, B. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06785.x · Cited by 304
Zhao, W., Rasheed, A., Tikkanen, E., Lee, J., Butterworth, A. S., Howson, J. M. M., Assimes, T. L., Chowdhury, R., Orho‐Melander, M., Damrauer, S. M., et al. (2017) · Nature Genetics · doi:10.1038/ng.3943 · Cited by 263
Ligthart, S., van Herpt, T. T. W., Leening, M. J. G., Kavousi, M., Hofman, A., Stricker, B. H. C., van Hoek, M., Sijbrands, E. J. G., Franco, O. H., & Dehghan, A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00362-9 · Cited by 267
β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes
Saisho, Y. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.109 · Cited by 263
Anti-diabetic polysaccharides from natural sources: A review
Wang, P.-C., Zhao, S., Yang, B., Wang, Q., & Kuang, H. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.02.060 · Cited by 262
Current efforts and trends in the treatment of NASH
Ratziu, V., Goodman, Z. D., & Sanyal, A. J. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.041 · Cited by 268
Johnson, J. A., Carstensen, B., Witte, D. R., Bowker, S. L., Lipscombe, L. L., & Renehan, A. G. (2012) · Diabetologia · doi:10.1007/s00125-012-2525-1 · Cited by 262
Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management
Sattar, N. A., & Gill, J. M. R. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00326-5 · Cited by 268
Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
Ferrannini, E., & DeFronzo, R. A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv239 · Cited by 265
Obesity, Type 2 Diabetes, and Cancer Risk
Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615375 · Cited by 289
Udell, J. A., Cavender, M. A., Bhatt, D. L., Chatterjee, S., Farkouh, M. E., & Scirica, B. M. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00044-3 · Cited by 254
Wormser, D., Angelantonio, E. D., Kaptoge, S. K., Wood, A., Gao, P., Sun, Q., Walldius, G., Selmer, R. M., Verschuren, W. M. M., Bueno-de-Mesquita, H. B., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys086 · Cited by 253
Managing comorbidities in COPD
Tzanakis, Ν., Hillas, G., Perlikos, F., & Tsiligianni, I. (2015) · International Journal of COPD · doi:10.2147/copd.s54473 · Cited by 267
Higher spermidine intake is linked to lower mortality: a prospective population-based study
Kiechl, S. J., Pechlaner, R., Willeit, P., Notdurfter, M., Paulweber, B., Willeit, K., Werner, P., Ruckenstuhl, C., Iglseder, B., Weger, S., et al. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy102 · Cited by 257
Mosenzon, O., Alguwaihes, A. M., Leon, J. L. A., Bayram, F., Darmon, P., Davis, T. M. E., Dieuzeide, G., Eriksen, K. T., Hong, T., Kaltoft, M. S., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01344-0 · Cited by 259
Lodhi, I. J., Yin, L., Jensen-Urstad, A. P. L., Funai, K., Coleman, T., Baird, J. H., Ramahi, M. K. E., Razani, B., Song, H., Hsu, F., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.013 · Cited by 253
Diabetes mellitus and cancer risk: Review of the epidemiological evidence
Shikata, K., Ninomiya, T., & Kiyohara, Y. (2012) · Cancer Science · doi:10.1111/cas.12043 · Cited by 247
Ke, C., Narayan, K. M. V., Chan, J. C. N., Jha, P., & Shah, B. R. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00669-4 · Cited by 263
Brownrigg, J. R. W., Hughes, C. O., Burleigh, D., Karthikesalingam, A., Patterson, B. O., Holt, P. J., Thompson, M. M., de Lusignan, S., Ray, K. K., & Hinchliffe, R. J. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30057-2 · Cited by 242
Aune, D., Feng, T., Schlesinger, S., Janszky, I., Norat, T., & Ríboli, E. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.02.004 · Cited by 251
Prediabetes and the risk of cancer: a meta-analysis
Huang, Y., Cai, X., Qiu, M., Chen, P., Tang, H., Huang, Y., & Huang, Y. (2014) · Diabetologia · doi:10.1007/s00125-014-3361-2 · Cited by 240
Kaptoge, S. K., Seshasai, S., Sun, L., Walker, M., Bolton, T., Spackman, S., Ataklte, F., Willeit, P., Bell, S., Burgess, S., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00223-1 · Cited by 255
Diabetes and Nonalcoholic Fatty Liver Disease: A Pathogenic Duo
Williams, K., Shackel, N. A., Gorrell, M. D., McLennan, S. V., & Twigg, S. M. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1009 · Cited by 235
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
Tateishi, R., Uchino, K., Fujiwara, N., Takehara, T., Okanoue, T., Seike, M., Yoshiji, H., Yatsuhashi, H., Shimizu, M., Torimura, T., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1532-5 · Cited by 236
Ding, X., Jian, T., Wu, Y., Zuo, Y., Li, J., Lv, H., Ma, L., Ren, B., Zhao, L., Li, W., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.018 · Cited by 258
Jin, C., Chen, S., Vaidya, A., Wu, Y., Wu, Z., Hu, F. B., Kris‐Etherton, P. M., Wu, S., & Gao, X. (2017) · Diabetes Care · doi:10.2337/dc17-0610 · Cited by 228
Fadini, G. P., Morieri, M. L., Boscari, F., Fioretto, P., Maran, A., Busetto, L., Bonora, B. M., Selmin, E., Arcidiacono, G. P., Pinelli, S., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108374 · Cited by 235
Association between adherence to pharmacotherapy and outcomes in type 2 diabetes: a meta-analysis
Khunti, K., Seidu, S., Kunutsor, S., & Davies, M. (2017) · Diabetes Care · doi:10.2337/dc16-1925 · Cited by 231
Komiya, C., Tsuchiya, K., Shiba, K., Miyachi, Y., Furuke, S., Shimazu, N., Yamaguchi, S., Kanno, K., & Ogawa, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151511 · Cited by 232
Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes
Lu, J., Ma, X., Shen, Y., Wu, Q. E., Wang, R., Zhang, L., Mo, Y., Lu, W., Zhu, W., Bao, Y., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0251 · Cited by 230
Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity
Anhê, F. F., Jensen, B. A. H., Varin, T. V., Servant, F., Blerk, S. V., Richard, D., Marceau, S., Surette, M. G., Biertho, L. D., Lelouvier, B., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0178-9 · Cited by 237
Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
Holman, R. R., Sourij, H., & Califf, R. M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60794-7 · Cited by 227
The Longitudinal Aging Study Amsterdam: cohort update 2016 and major findings
Hoogendijk, E. O., Deeg, D. J. H., Poppelaars, J. L., van der Horst, M. H. L., Groenou, M. I. B. V., Comijs, H. C., Pasman, H. R. W., van Schoor, N. M., Suanet, B., Thomése, F., et al. (2016) · European Journal of Epidemiology · doi:10.1007/s10654-016-0192-0 · Cited by 227
Diabetes Mellitus, Prediabetes, and Incidence of Subclinical Myocardial Damage
Selvin, E., Lazo, M., Chen, Y., Shen, L., Rubin, J., McEvoy, J. W., Hoogeveen, R. C., Sharrett, A. R., Ballantyne, C. M., & Coresh, J. (2014) · Circulation · doi:10.1161/circulationaha.114.010815 · Cited by 231
Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor
Udell, J. A., Yuan, Ž., Rush, T. M., Sicignano, N., Galitz, M. S., & Rosenthal, N. R. (2017) · Circulation · doi:10.1161/circulationaha.117.031227 · Cited by 228
Gnatiuc, L., Herrington, W. G., Halsey, J., Tuomilehto, J., Fang, X., Kim, H., Bacquer, D. D., Dobson, A. J., Criqui, M. H., Jacobs, D. R., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30079-2 · Cited by 225
Diabetes mellitus in patients with cirrhosis: clinical implications and management
Elkrief, L., Rautou, P., Sarin, S. K., Valla, D. C., Paradis, V., & Moreau, R. (2016) · Liver International · doi:10.1111/liv.13115 · Cited by 228
Xu, H., Aldrich, M. C., Chen, Q., Liu, H., Peterson, N. B., Dai, Q., Levy, M. A., Shah, A., Han, X., Ruan, X., et al. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002649 · Cited by 221
Lin, J. S., Evans, C. V., Johnson, E., Redmond, N., Coppola, E. L., & Smith, N. (2018) · JAMA · doi:10.1001/jama.2018.4242 · Cited by 216
Insulin, insulin receptors, and cancer
Vigneri, R., Goldfine, I. D., & Frittitta, L. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0508-7 · Cited by 224
Stefan, N., & Schulze, M. B. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00086-4 · Cited by 215
de Bruijn, K. M. J., Arends, L. R., Hansen, B. E., Leeflang, S., Ruiter, R., & van Eijck, C. H. J. (2013) · British journal of surgery · doi:10.1002/bjs.9229 · Cited by 214
Ahola‐Olli, A., Mustelin, L., Kalimeri, M., Kettunen, J., Jokelainen, J. J., AUVINEN, J. P., Puukka, K. S., Havulinna, A. S., Lehtimäki, T. J., Kähönen, M. A. P., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-05001-w · Cited by 221
Hernandez-Romieu, A. C., Garg, S., Rosenberg, E. S., Thompson-Paul, A. M., & Skarbinski, J. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000304 · Cited by 213
Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality
Fernandez, C., Rysä, J., Almgren, P., Nilsson, J. Å., Engström, G., Orho‐Melander, M., Ruskoaho, H. J., & Melander, O. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12783 · Cited by 216
Increased Risk of Pneumonia Among Patients With Inflammatory Bowel Disease
Long, M. D., Martin, C. F., Sandler, R. S., & Kappelman, M. D. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.406 · Cited by 209
Diabetes and Altered Glucose Metabolism with Aging
Kalyani, R. R., & Egan, J. M. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.02.010 · Cited by 218
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
Klil-Drori, A. J., Azoulay, L., & Pollak, M. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.120 · Cited by 212
Phenotypes of prediabetes and stratification of cardiometabolic risk
Stefan, N., Fritsche, A., Schick, F., & Häring, H.-U. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00082-6 · Cited by 208
Schmidt, M. I., Hoffmann, J. F., Diniz, M. D. F. H. S., Lotufo, P. A., Griep, R. H., Benseñor, I. M., Mill, J. G., Barreto, S. M., Aquino, E. M. L., & Duncan, B. B. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-123 · Cited by 212
Wang, Y., O'Neil, A. E., Jiao, Y., Wang, L., Huang, J., Lan, Y., Zhu, Y., & Yu, C. (2019) · BMC Medicine · doi:10.1186/s12916-019-1355-0 · Cited by 213
Liver and diabetes. A vicious circle
Loria, P., Lonardo, A., & Anania, F. A. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01031.x · Cited by 208
Chen, Y., Wu, F., Saito, E., Lin, Y., Song, M., Luu, H. N., Gupta, P. C., Sawada, N., Tamakoshi, A., Shu, X., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4229-z · Cited by 207
Impact of the Obesity Epidemic on Cancer
Goodwin, P. J., & Stambolic, V. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-051613-012328 · Cited by 211
Ji, X., Guo, J., Cao, T., Zhang, T., Liu, Y., & Yan, Y. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.03.017 · Cited by 213
Nanotechnology based approaches for anti-diabetic drugs delivery
Kesharwani, P., Gorain, B., Low, S. Y., Tan, S. A., Ling, E. C. S., Lim, Y. K., Chin, C. M., Lee, P. Y., Lee, C. M., Ooi, C. H., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.11.018 · Cited by 204
Sharif, S., Van der Graaf, Y., Cramer, M. J., Kapelle, L. J., de Borst, G. J., Visseren, F. L. J., Westerink, J., the SMART study group, van Petersen, R., Dinther, B. G. F., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01409-0 · Cited by 198
Glycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease?
Saisho, Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018381 · Cited by 204
Periodontal disease, edentulism, and pancreatic cancer: a meta-analysis
Maisonneuve, P., Amar, S., & Lowenfels, A. B. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx019 · Cited by 206
Nonalcoholic fatty liver disease: Evolving paradigms
Lonardo, A., Nascimbeni, F., Maurantonio, M., Marrazzo, A., Rinaldi, L., & Adinolfi, L. E. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6571 · Cited by 204
Association between the triglyceride–glucose index and severity of coronary artery disease
Wang, X., Xu, W., Song, Q., Zhao, Z., Meng, X., Xia, C., Xie, Y., Yang, C., Jin, P., & Wang, F. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01606-5 · Cited by 201
Chang, C., Lin, J., Wu, L., Lai, M., Chuang, L., & Chan, K. A. (2011) · Hepatology · doi:10.1002/hep.25509 · Cited by 193
Cancer risk associated with chronic diseases and disease markers: prospective cohort study
Tu, H., Wen, C. P., Tsai, S. P., Chow, W., Wen, C., Ye, Y., Zhao, H., Tsai, M. K., Huang, M., Dinney, C. P., et al. (2018) · BMJ · doi:10.1136/bmj.k134 · Cited by 192
Dryden, M., Baguneid, M. S., Eckmann, C., Corman, S. L., Stephens, J., Solem, C. T., Li, J., Charbonneau, C., Baillon-Plot, N., & Haider, S. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.03.024 · Cited by 190
DPP4 in Cardiometabolic Disease
Zhong, J., Maiseyeu, A., Davis, S. N., & Rajagopalan, S. (2015) · Circulation Research · doi:10.1161/circresaha.116.305665 · Cited by 190
Diabetes and Cancer: Risk, Challenges, Management and Outcomes
Shahid, R. K., Ahmed, S., Le, D., & Yadav, S. (2021) · Cancers · doi:10.3390/cancers13225735 · Cited by 187
Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies
Batabyal, P., Hoorn, S. V., Christophi, C., & Nikfarjam, M. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3625-6 · Cited by 189
The Signaling of Cellular Senescence in Diabetic Nephropathy
Xiong, Y., & Zhou, L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7495629 · Cited by 185
Nead, K. T., Sharp, S. J., Thompson, D. J., Painter, J. N., Savage, D. B., Semple, R. K., Barker, A., Perry, J. R. B., Attia, J., Dunning, A. M., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv178 · Cited by 189
Stevens, R. J., Ali, R., Bankhead, C. R., Bethel, M. A., Cairns, B. J., Camisasca, R. P., Crowe, F. L., Farmer, A. J., Harrison, S., Hirst, J. A., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2653-7 · Cited by 161
The Effect of n-3 Fatty Acids on Glucose Homeostasis and Insulin Sensitivity
Flachs, P., Rossmeisl, M., & Kopecký, J. (2014) · Physiological Research · doi:10.33549/physiolres.932715 · Cited by 190
Guideline for management of postmeal glucose in diabetes
1 (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.08.002 · Cited by 185
Bonapace, S., Perseghin, G., Molon, G., Canali, G., Bertolini, L., Zoppini, G., Barbieri, E., & Targher, G. (2011) · Diabetes Care · doi:10.2337/dc11-1820 · Cited by 182
Qiao, T., Luo, T., Pei, H., Yimingniyazi, B., Aili, D., Aimudula, A., Zhao, H., Zhang, H., Dai, J., & Wang, D. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01670-x · Cited by 183
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults
Borena, W., Strohmaier, S., Lukanova, A., Bjørge, T., Lindkvist, B., Hallmans, G., Edlinger, M., Stocks, T., Nagel, G., Manjer, J., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26338 · Cited by 177
Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia
Yang, J. J., Yu, D., Wen, W., Saito, E., Rahman, M. S., Shu, X., Chen, Y., Gupta, P. C., Gu, D., Tsugane, S., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.2696 · Cited by 177
Guraya, S. Y. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i19.6026 · Cited by 179
Rana, J. S., Dunning, A. M., Achenbach, S. S., Al-Mallah, M. H., Budoff, M. J., Cademartiri, F., Callister, T. Q., Chang, H., Cheng, V., Chinnaiyan, K. M., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2403 · Cited by 176
Shiba, K., Tsuchiya, K., Komiya, C., Miyachi, Y., Mori, K., Shimazu, N., Yamaguchi, S., Ogasawara, N., Katoh, M., Itoh, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19658-7 · Cited by 177
Cardiovascular effects of gliptins
Scheen, A. J. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.183 · Cited by 175
Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes
Yamagishi, S., Nakamura, N., Suematsu, M., Kaseda, K., & Matsui, T. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00067 · Cited by 179
Sonesson, C., Johansson, P. A., JOHNSSON, E. K., & Gause‐Nilsson, I. A. M. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0356-y · Cited by 181
Transdermal Electrochemical Monitoring of Glucose via High‐Density Silicon Microneedle Array Patch
Dervisevic, M., Alba, M., Yan, L., Şenel, M., Gengenbach, T. R., Prieto‐Simón, B., & Voelcker, N. H. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202009850 · Cited by 174
Lovshin, J. A., Barnie, A., DeAlmeida, A., Logan, A., Zinman, B., & Drucker, D. J. (2015) · Diabetes Care · doi:10.2337/dc14-1958 · Cited by 168
Mortality From Chronic Liver Diseases in Diabetes
Zoppini, G., Fedeli, U., Gennaro, N., Saugo, M., Targher, G., & Bonora, E. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.132 · Cited by 172
The Adiponectin Paradox for All-Cause and Cardiovascular Mortality
Menzaghi, C., & Trischitta, V. (2017) · Diabetes · doi:10.2337/dbi17-0016 · Cited by 172
Tillin, T., Hughes, A. D., Godsland, I. F., Whincup, P. H., Forouhi, N. G., Welsh, P. I., Sattar, N. A., McKeigue, P., & Chaturvedi, N. (2012) · Diabetes Care · doi:10.2337/dc12-0544 · Cited by 170
Dong, J.-Y., Zhang, Z.-L., Wang, P.-Y., & Qin, L.-Q. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513002055 · Cited by 163
Toumpanakis, A., Turnbull, T., & Alba-Barba, I. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000534 · Cited by 170
Mantovani, A., & Targher, G. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.04.41 · Cited by 170
for the Renal Insufficiency And Cardiovascular Events (RIACE) Study Group, Penno, G., Solini, A., Orsi, E., Bonora, E., Fondelli, C., Trevisan, R., Vedovato, M., Cavalot, F. L., Zerbini, G., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-01936-3 · Cited by 173
The Relationship Between Diabetes Mellitus and Cancers and Its Underlying Mechanisms
Zhu, B., & Qu, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.800995 · Cited by 174
Pang, Y., Kartsonaki, C., Turnbull, I. J., Yu, C., Clarke, R., Chen, Y., Bragg, F., Yang, L., Bian, Z., Millwood, I. Y., et al. (2018) · Hepatology · doi:10.1002/hep.30083 · Cited by 166
Silva, F. D., & Alcorn, J. (2019) · Pharmaceuticals · doi:10.3390/ph12020068 · Cited by 168
Periodontitis and implant complications in diabetes
Nibali, L., Gkranias, N., Mainas, G., & Pino, A. D. (2022) · Periodontology 2000 · doi:10.1111/prd.12451 · Cited by 187
Improvement in cardiovascular outcomes with empagliflozin is independent of glycemic control
Inzucchi, S. E., Kosiborod, M., Fitchett, D., Wanner, C., Hehnke, U., Kaspers, S., George, J. T., & Zinman, B. (2018) · Circulation · doi:10.1161/circulationaha.118.035759 · Cited by 162
Lind, M., García‐Rodríguez, L. A., Booth, G. L., Soriano, L. C., Shah, B. R., Ekeroth, G., & Lipscombe, L. L. (2013) · Diabetologia · doi:10.1007/s00125-013-3063-1 · Cited by 167
Premature Mortality and Comorbidities in Young-onset Diabetes: A 7-Year Prospective Analysis
Chan, J. C. N., Lau, E. S. H., Luk, A. O. Y., Cheung, K. K.-T., Kong, A. P. S., Yu, L. W. L., Choi, K. C., Chow, F. C. C., Ozaki, R., Brown, N., et al. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.03.018 · Cited by 167
Metadata
- Authors
- The Emerging Risk Factors Collaboration
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- The Emerging Risk Factors Collaboration
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-03-03
- Volume
- 364
- Issue
- 9
- Pages
- 829-841
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4109980
- OpenAlex
- W2126919962
- Semantic Scholar
- a89247dcde559e5839cef19b130059e2ad9abc75
- Cited by
- 2,726
- References
- 40
- Citations by year
- 2026: 102 · 2025: 138 · 2024: 186 · 2023: 151 · 2022: 200 · 2021: 225 · 2020: 218 · 2019: 182 · 2018: 190 · 2017: 203 · 2016: 190 · 2015: 196 · 2014: 193 · 2013: 145 · 2012: 147
- FWCI
- 141.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Socio-Environmental Systems Modeling (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Site cant be reached (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- OPUS (Augsburg University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- British Heart Foundation (RG/08/013/25942, RG/08/014, PG/09/002/26056, RG/07/008/23674, RG/08/014/24067)
- National Institutes of Health (n01hc085082-026, n01hc085081-021, n01hc085079-024, n01hc085083-027, n01hc085080-026, n01hc085086-022, UL1TR000062, n01hc55222-0-0-0)
- Economic and Social Research Council (ES/G007438/1)
- National Institute on Aging (R01AG023629)
- National Heart, Lung, and Blood Institute (N01 HC085086, N01 HC085079, N01 HC085083, N01 HC085080, HHSN 268200800007C, N01HC085082, U01HL080295, N01 HC055222, N01 HC085081)
- National Center for Research Resources (UL1RR025014)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, fasting blood glucose, hyperglycemia, cause-specific mortality, cancer mortality, vascular death, premature mortality, liver cancer, pancreatic cancer, ovarian cancer, colorectal cancer, lung cancer, breast cancer, renal disease mortality, infectious disease mortality, intentional self-harm, chronic obstructive pulmonary disease, mortality risk factors
- MeSH terms
- Blood Glucose, Cause of Death, Diabetes Mellitus, Female, Humans, Hyperglycemia, Life Expectancy, Male, Middle Aged, Risk, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
